Latest Post

December 28, 2020

Particles in Injectable Drugs

A parenteral drug product contaminated by particles is a potential health threat. In the bloodstream, particles can cause serious issues, such as capillary occlusion and immunogenic responses. In most cases, the observation of particles in a drug product leads to a recall.
Lynn Yao

Lynn Yao

Manager, Scientific Affairs, CN

Previous Posts
Particle Analysis

June 11, 2019

Particulate Challenges

Fran DeGrazio

Fran DeGrazio

V.P. Technical Customer Service & Scientific Affairs

Leo Posner of Johnson & Johnson presenting at the PDA Combo Workshop

April 03, 2019

The Challenges of Combination Products

Fran DeGrazio

Fran DeGrazio

VP, Technical Services and Scientific Affairs

Compatibility issues Chart

March 07, 2019

Simplify the Journey™ - Integrated Solutions for Particles

Doug Hostetler

Doug Hostetler

Sr Manager, Integrated Solutions, Lab

Particle Testing

March 01, 2019

Achieving ″Zero″ Defects for Visible Particles in Injectables

Olga Laskina

Olga Laskina

Sr Tech Acct Spec, TCS, NA

Leur Lock Syringes

February 25, 2019

Particles in Intravitreal Injections - Part II

Susan Dounce

Susan Dounce

Principal SME, PFS CZ, TCS

Load more